Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

imaging

  • You have access
    The Glucose-Dependent Insulinotropic Polypeptide Receptor: A Novel Target for Neuroendocrine Tumor Imaging—First Preclinical Studies
    Eleni Gourni, Beatrice Waser, Pascal Clerc, Daniel Fourmy, Jean Claude Reubi and Helmut R. Maecke
    Journal of Nuclear Medicine June 1, 2014, 55 (6) 976-982; DOI: https://doi.org/10.2967/jnumed.113.133744
  • You have access
    Imaging the Folate Receptor on Cancer Cells with 99mTc-Etarfolatide: Properties, Clinical Use, and Future Potential of Folate Receptor Imaging
    Alan H. Maurer, Philip Elsinga, Stefano Fanti, Binh Nguyen, Wim J.G. Oyen and Wolfgang A. Weber
    Journal of Nuclear Medicine May 1, 2014, 55 (5) 701-704; DOI: https://doi.org/10.2967/jnumed.113.133074
  • You have access
    Tyrosine Kinase Inhibitor Sorafenib Decreases 111In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma
    Constantijn H.J. Muselaers, Alexander B. Stillebroer, Ingrid M.E. Desar, Marye J. Boers-Sonderen, Carla M.L. van Herpen, Mirjam C.A. de Weijert, Johan F. Langenhuijsen, Egbert Oosterwijk, William P.J. Leenders, Otto C. Boerman, Peter F.A. Mulders and Wim J.G. Oyen
    Journal of Nuclear Medicine February 1, 2014, 55 (2) 242-247; DOI: https://doi.org/10.2967/jnumed.113.131110
  • You have access
    Molecular Imaging of Prostate Cancer with PET
    Hossein Jadvar
    Journal of Nuclear Medicine October 1, 2013, 54 (10) 1685-1688; DOI: https://doi.org/10.2967/jnumed.113.126094
  • You have access
    In Vivo PET/CT in a Human Glioblastoma Chicken Chorioallantoic Membrane Model: A New Tool for Oncology and Radiotracer Development
    Geoff Warnock, Andrei Turtoi, Arnaud Blomme, Florian Bretin, Mohamed Ali Bahri, Christian Lemaire, Lionel Cyrille Libert, Alain E.J.J. Seret, André Luxen, Vincenzo Castronovo and Alain R.E.G. Plenevaux
    Journal of Nuclear Medicine October 1, 2013, 54 (10) 1782-1788; DOI: https://doi.org/10.2967/jnumed.112.117150
  • You have access
    A PET-Compatible Tissue Bioreactor for Research, Discovery, and Validation of Imaging Biomarkers and Radiopharmaceuticals: System Design and Proof-of-Concept Studies
    Timothy D. Whitehead, Samuel T. Nemanich, Carmen Dence and Kooresh I. Shoghi
    Journal of Nuclear Medicine October 1, 2013, 54 (10) 1812-1819; DOI: https://doi.org/10.2967/jnumed.113.119776
  • You have access
    99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer
    Shawn M. Hillier, Kevin P. Maresca, Genliang Lu, Ross D. Merkin, John C. Marquis, Craig N. Zimmerman, William C. Eckelman, John L. Joyal and John W. Babich
    Journal of Nuclear Medicine August 1, 2013, 54 (8) 1369-1376; DOI: https://doi.org/10.2967/jnumed.112.116624
  • You have access
    Assessment of the 18F-Labeled PET Tracer LMI1195 for Imaging Norepinephrine Handling in Rat Hearts
    Takahiro Higuchi, Behrooz H. Yousefi, Franz Kaiser, Florian Gärtner, Christoph Rischpler, Sybille Reder, Ming Yu, Simon Robinson, Marcus Schwaiger and Stephan G. Nekolla
    Journal of Nuclear Medicine July 1, 2013, 54 (7) 1142-1146; DOI: https://doi.org/10.2967/jnumed.112.104232
  • You have access
    Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association
    Keith A. Johnson, Satoshi Minoshima, Nicolaas I. Bohnen, Kevin J. Donohoe, Norman L. Foster, Peter Herscovitch, Jason H. Karlawish, Christopher C. Rowe, Maria C. Carrillo, Dean M. Hartley, Saima Hedrick, Virginia Pappas and William H. Thies
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 476-490; DOI: https://doi.org/10.2967/jnumed.113.120618
  • You have access
    Barriers to Clinical Translation with Diagnostic Drugs
    Lee Josephson and Markus Rudin
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 329-332; DOI: https://doi.org/10.2967/jnumed.112.107615

Pages

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire